Tokio Marine Asset Management CO LTD Regeneron Pharmaceuticals, Inc. Transaction History

Tokio Marine Asset Management CO LTD

$2.25 Billion
Q3 2024

A detailed history of Tokio Marine Asset Management CO LTD transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Tokio Marine Asset Management CO LTD holds 3,227 shares of REGN stock, worth $2.39 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

3,227

Previous 3,021 6.82%

Holding current value

$2.39 Million

Previous $3.18 Million 6.83%

% of portfolio

0.15%

Previous 0.15%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	BUY	$1024.09 - $1201.76 $210,962 - $247,562	206 Added 6.82%	3,227 $3.39 Million
Q2 2024 Jul 26, 2024	BUY	$883.2 - $1071.19 $298,521 - $362,062	338 Added 12.6%	3,021 $3.18 Million
Q1 2024 May 02, 2024	BUY	$902.69 - $993.35 $237,407 - $261,251	263 Added 10.87%	2,683 $2.58 Million
Q4 2023 Feb 02, 2024	BUY	$775.18 - $881.7 $62,789 - $71,417	81 Added 3.46%	2,420 $2.13 Million
Q3 2023 Nov 02, 2023	BUY	$692.45 - $844.37 $128,795 - $157,052	186 Added 8.64%	2,339 $1.92 Million
Q2 2023 Jul 28, 2023	BUY	$700.03 - $830.35 $68,602 - $81,374	98 Added 4.77%	2,153 $1.55 Million
Q1 2023 May 11, 2023	BUY	$680.49 - $826.97 $168,081 - $204,261	247 Added 13.66%	2,055 $1.69 Million
Q4 2022 Jan 26, 2023	BUY	$705.89 - $766.39 $118,589 - $128,753	168 Added 10.24%	1,808 $0
Q3 2022 Nov 10, 2022	BUY	$573.97 - $724.32 $141,196 - $178,182	246 Added 17.65%	1,640 $1.13 Million
Q2 2022 Aug 09, 2022	BUY	$548.35 - $738.84 $106,928 - $144,073	195 Added 16.26%	1,394 $824,000
Q1 2022 May 13, 2022	SELL	$595.12 - $698.43 $245,189 - $287,753	-412 Reduced 25.57%	1,199 $837,000
Q4 2021 Jan 26, 2022	BUY	$543.48 - $670.97 $53,804 - $66,426	99 Added 6.55%	1,611 $1.02 Million
Q3 2021 Nov 15, 2021	BUY	$574.03 - $680.96 $314,568 - $373,166	548 Added 56.85%	1,512 $915,000
Q2 2021 Aug 12, 2021	BUY	$472.8 - $558.54 $102,124 - $120,644	216 Added 28.88%	964 $538,000
Q1 2021 May 17, 2021	SELL	$446.73 - $548.2 $763,461 - $936,873	-1,709 Reduced 69.56%	748 $354,000
Q4 2020 Feb 16, 2021	BUY	$478.3 - $607.98 $182,232 - $231,640	381 Added 18.35%	2,457 $1.19 Million
Q3 2020 Nov 09, 2020	BUY	$544.75 - $658.21 $369,340 - $446,266	678 Added 48.5%	2,076 $1.16 Million
Q2 2020 Aug 07, 2020	BUY	$493.32 - $643.92 $689,661 - $900,200	1,398 New	1,398 $872,000
Q4 2017 Feb 05, 2018	SELL	$358.63 - $469.95 $242,433 - $317,686	-676 Closed	0 $0
Q3 2017 Oct 30, 2017	SELL	$431.38 - $504.0 $96,197 - $112,392	-223 Reduced 24.81%	676 $302,000
Q2 2017 Jan 11, 2018	SELL	N/A	-347 Reduced 27.85%	899 $442,000
Q1 2017 Jan 11, 2018	SELL	N/A	-332 Reduced 21.04%	1,246 $483,000
Q4 2016 Jan 11, 2018	SELL	N/A	-580 Reduced 26.88%	1,578 $579,000
Q3 2016 Jan 11, 2018	SELL	N/A	-193 Reduced 8.21%	2,158 $868,000
Q2 2016 Jan 11, 2018	SELL	N/A	-84 Reduced 3.45%	2,351 $821,000
Q1 2016 Jan 11, 2018	BUY	N/A	2,435	2,435 $878,000

Others Institutions Holding REGN

# of Institutions

1,535

Shares Held

83.8M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $79.3B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tokio Marine Asset Management CO LTD, based on Form 13F filings with the SEC.

News

Stay updated on Tokio Marine Asset Management CO LTD with notifications on news.

Account

Tokio Marine Asset Management CO LTD Regeneron Pharmaceuticals, Inc. Transaction History